These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17163246)

  • 1. Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease.
    Shmelev EI; Kunicina YL
    Clin Drug Investig; 2006; 26(3):151-9. PubMed ID: 17163246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study.
    Shute JK; Calzetta L; Cardaci V; di Toro S; Page CP; Cazzola M
    Pulm Pharmacol Ther; 2018 Feb; 48():88-96. PubMed ID: 28986203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M; Bosse S; Oltmanns U; Schumacher A; Witt C
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness of fenspiride in the treatment of patients with chronic obstructive pulmonary disease].
    Butorov SI; Muntianu VI
    Klin Med (Mosk); 2007; 85(5):43-7. PubMed ID: 17665604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].
    Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН
    Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicofunctional condition and quality of life in patients with chronic obstructive pulmonary disease before and after outpatient treatment with fenspiride].
    Butorov SI; Butorov IV; Bodrug NI; Krushka SI; Tofan EF
    Ter Arkh; 2008; 80(3):24-8. PubMed ID: 18441679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
    Singh D; Corradi M; Spinola M; Papi A; Usmani OS; Scuri M; Petruzzelli S; Vestbo J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2917-2928. PubMed ID: 29062229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
    Vestbo J; Papi A; Corradi M; Blazhko V; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Singh D
    Lancet; 2017 May; 389(10082):1919-1929. PubMed ID: 28385353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.
    Wedzicha JA; Singh D; Vestbo J; Paggiaro PL; Jones PW; Bonnet-Gonod F; Cohuet G; Corradi M; Vezzoli S; Petruzzelli S; Agusti A;
    Respir Med; 2014 Aug; 108(8):1153-62. PubMed ID: 24953015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
    Nishimura K; Ikeda A; Koyama H; Zhang M; Tsukino M; Hajiro T; Izumi T
    Pulm Pharmacol Ther; 2000; 13(5):225-30. PubMed ID: 11001866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose inhaled beclomethasone dipropionate and maximal improvements in patients with stable chronic obstructive pulmonary disease].
    Zhang M; Nishimura K; Ikeda A; Tsukino M; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1386-1391. PubMed ID: 8821992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of basic therapy on clinical symptoms, quality of life and systemic inflammation in patients with chronic obstructive pulmonary disease].
    Baranova II; Leshchenko IV
    Klin Med (Mosk); 2013; 91(12):21-5. PubMed ID: 25702425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.
    Terzano C; Petroianni A; Ricci A; Allegra L
    Eur Rev Med Pharmacol Sci; 2005; 9(4):209-15. PubMed ID: 16128040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
    Calverley PM; Kuna P; Monsó E; Costantini M; Petruzzelli S; Sergio F; Varoli G; Papi A; Brusasco V
    Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study).
    Singh D; Schröder-Babo W; Cohuet G; Muraro A; Bonnet-Gonod F; Petruzzelli S; Hoffmann M; Siergiejko Z;
    Respir Med; 2016 May; 114():84-90. PubMed ID: 27109816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation and symptomatic treatment of surinfectious exacerbations of COPD: preliminary study of antibiotic treatment combined with fenspiride (Pneumorel 80mg) versus placebo].
    Lirsac B; Benezet O; Dansin E; Nouvet G; Stach B; Voisin C
    Rev Pneumol Clin; 2000 Feb; 56(1):17-24. PubMed ID: 10740110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
    Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD.
    Sugiura H; Ichinose M; Yamagata S; Koarai A; Shirato K; Hattori T
    Thorax; 2003 Apr; 58(4):299-305. PubMed ID: 12668791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.